Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Busulfan × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 9 Myelodysplastic Syndromes 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myeloproliferative Disorders 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Primary Myelofibrosis 1 Preleukemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Neuroblastoma 1 Neoplasms by Histologic Type 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lymphatic Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hemoglobinopathies 1 Hematologic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4 Biopsy 3 X-Rays 2 Specimen Handling 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 regorafenib 1 pembrolizumab 1 erdafitinib 1 ensartinib 1 cabozantinib 1 alectinib 1 aflibercept 1 Surveys and Questionnaires 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 ONC206 1 Nivolumab 1 NEO212 1 Lomustine 1 Ipilimumab 1 IFL protocol 1 Gadolinium 1 Ferrosoferric Oxide 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡